Literature DB >> 22926415

MicroRNAs in breast cancer initiation and progression.

Huiping Liu1.   

Abstract

The emerging role of microRNAs (miRNAs) in the epigenetic regulation of many cellular processes has become recognized in both basic research and translational medicine as an important way that gene expression can be fine-tuned. Breast cancer is the most frequent cancer in women, with about one million new cases diagnosed each year worldwide. Starting with the early work of miRNA profiling, more effort has now been put on functions of miRNAs in normal mammary stem cells, breast cancer initiating cells and metastatic cells, and therapy-resistant cancer cells. Future translational studies may focus on identifying miRNA signatures as cancer biomarkers and developing miRNA-based targeted therapeutics.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22926415      PMCID: PMC3513350          DOI: 10.1007/s00018-012-1128-9

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  114 in total

1.  Analyzing real-time PCR data by the comparative C(T) method.

Authors:  Thomas D Schmittgen; Kenneth J Livak
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

2.  LNA-mediated microRNA silencing in non-human primates.

Authors:  Joacim Elmén; Morten Lindow; Sylvia Schütz; Matthew Lawrence; Andreas Petri; Susanna Obad; Marie Lindholm; Maj Hedtjärn; Henrik Frydenlund Hansen; Urs Berger; Steven Gullans; Phil Kearney; Peter Sarnow; Ellen Marie Straarup; Sakari Kauppinen
Journal:  Nature       Date:  2008-03-26       Impact factor: 49.962

3.  Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy.

Authors:  Xiaoxian Li; Michael T Lewis; Jian Huang; Carolina Gutierrez; C Kent Osborne; Meng-Fen Wu; Susan G Hilsenbeck; Anne Pavlick; Xiaomei Zhang; Gary C Chamness; Helen Wong; Jeffrey Rosen; Jenny C Chang
Journal:  J Natl Cancer Inst       Date:  2008-04-29       Impact factor: 13.506

4.  The epithelial-mesenchymal transition generates cells with properties of stem cells.

Authors:  Sendurai A Mani; Wenjun Guo; Mai-Jing Liao; Elinor Ng Eaton; Ayyakkannu Ayyanan; Alicia Y Zhou; Mary Brooks; Ferenc Reinhard; Cheng Cheng Zhang; Michail Shipitsin; Lauren L Campbell; Kornelia Polyak; Cathrin Brisken; Jing Yang; Robert A Weinberg
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

5.  The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2.

Authors:  Manav Korpal; Esther S Lee; Guohong Hu; Yibin Kang
Journal:  J Biol Chem       Date:  2008-04-14       Impact factor: 5.157

Review 6.  The cancer stem cell hypothesis: in search of definitions, markers, and relevance.

Authors:  Michail Shipitsin; Kornelia Polyak
Journal:  Lab Invest       Date:  2008-03-31       Impact factor: 5.662

7.  The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.

Authors:  Philip A Gregory; Andrew G Bert; Emily L Paterson; Simon C Barry; Anna Tsykin; Gelareh Farshid; Mathew A Vadas; Yeesim Khew-Goodall; Gregory J Goodall
Journal:  Nat Cell Biol       Date:  2008-03-30       Impact factor: 28.824

8.  Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin.

Authors:  Olga Kovalchuk; Jody Filkowski; James Meservy; Yaroslav Ilnytskyy; Volodymyr P Tryndyak; Vasyl' F Chekhun; Igor P Pogribny
Journal:  Mol Cancer Ther       Date:  2008-07       Impact factor: 6.261

9.  A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells.

Authors:  Ulrike Burk; Jörg Schubert; Ulrich Wellner; Otto Schmalhofer; Elizabeth Vincan; Simone Spaderna; Thomas Brabletz
Journal:  EMBO Rep       Date:  2008-05-16       Impact factor: 8.807

10.  Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM.

Authors:  Laura Fontana; Micol E Fiori; Sonia Albini; Loredana Cifaldi; Serena Giovinazzi; Matteo Forloni; Renata Boldrini; Alberto Donfrancesco; Valentina Federici; Patrizio Giacomini; Cesare Peschle; Doriana Fruci
Journal:  PLoS One       Date:  2008-05-21       Impact factor: 3.240

View more
  29 in total

1.  Circulating long noncoding RNA GAS5 as a potential biomarker in breast cancer for assessing the surgical effects.

Authors:  Lu Han; Pei Ma; Song-Mei Liu; Xin Zhou
Journal:  Tumour Biol       Date:  2015-12-10

2.  Up-regulation and worse prognostic marker of cytoplasmic TARBP2 expression in obstinate breast cancer.

Authors:  Xiaoti Lin; Minqing Wu; Peng Liu; Fengqin Wei; Laisheng Li; Hailin Tang; Xinhua Xie; Xiaoping Liu; Lu Yang; Xiaoming Xie
Journal:  Med Oncol       Date:  2014-02-22       Impact factor: 3.064

3.  Selective inhibition of miR-21 by phage display screened peptide.

Authors:  Debojit Bose; Smita Nahar; Manish Kumar Rai; Arjun Ray; Kausik Chakraborty; Souvik Maiti
Journal:  Nucleic Acids Res       Date:  2015-03-30       Impact factor: 16.971

4.  Aberrant miR-215 expression is associated with clinical outcome in breast cancer patients.

Authors:  Shu-wei Zhou; Bei-bei Su; Yong Zhou; Yue-qing Feng; Yu Guo; Yun-xiang Wang; Pan Qi; Sheng Xu
Journal:  Med Oncol       Date:  2014-10-01       Impact factor: 3.064

5.  Increased expression of microRNA-196a predicts poor prognosis in human ovarian carcinoma.

Authors:  Yi Fan; Jin Fan; Liu Huang; Ming Ye; Zheng Huang; Yibin Wang; Qiufen Li; Jiezhen Huang
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

Review 6.  The Dysregulation of MicroRNAs in the Development of Cervical Pre-Cancer-An Update.

Authors:  Pui-Wah Choi; Tin Lun Liu; Chun Wai Wong; Sze Kei Liu; Yick-Liang Lum; Wai-Kit Ming
Journal:  Int J Mol Sci       Date:  2022-06-27       Impact factor: 6.208

Review 7.  MicroRNAs in the control of metastatic bone disease.

Authors:  Gillian Browne; Hanna Taipaleenmäki; Gary S Stein; Janet L Stein; Jane B Lian
Journal:  Trends Endocrinol Metab       Date:  2014-05-05       Impact factor: 12.015

8.  MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion.

Authors:  Jessica Bockhorn; Kathy Yee; Ya-Fang Chang; Aleix Prat; Dezheng Huo; Chika Nwachukwu; Rachel Dalton; Simo Huang; Kaitlin E Swanson; Charles M Perou; Olufunmilayo I Olopade; Michael F Clarke; Geoffrey L Greene; Huiping Liu
Journal:  Breast Cancer Res Treat       Date:  2012-12-07       Impact factor: 4.872

9.  Decoding the cancer stem cell hypothesis in glioblastoma.

Authors:  James S Hale; Maksim Sinyuk; Jeremy N Rich; Justin D Lathia
Journal:  CNS Oncol       Date:  2013-07

Review 10.  Analysis of chromosome 17 miRNAs and their importance in medulloblastomas.

Authors:  Sebastian López-Ochoa; Marina Ramírez-García; Eduardo Castro-Sierra; Francisco Arenas-Huertero
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.